Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-05-2024 | Lenvatinib | Case report

Lenvatinib/pembrolizumab

Prothrombotic milieu

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Mohee K, et al. Prothrombotic Milieu in a Patient with Advanced Renal Cell Carcinoma on Immunotherapy. Journal of Cardiovascular Magnetic Resonance 26 (Suppl. 1): Jan 2024. Available from: URL: https://dx.doi.org/10.1016/j.jocmr.2024.100490 [abstract] Mohee K, et al. Prothrombotic Milieu in a Patient with Advanced Renal Cell Carcinoma on Immunotherapy. Journal of Cardiovascular Magnetic Resonance 26 (Suppl. 1): Jan 2024. Available from: URL: https://​dx.​doi.​org/​10.​1016/​j.​jocmr.​2024.​100490 [abstract]
Metadata
Title
Lenvatinib/pembrolizumab
Prothrombotic milieu
Publication date
01-05-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58260-5

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Tozinameran

Case report

Multiple drugs